This cross-sectional study evaluates a systematic drug appraisal method that uses severity of disease to account for a fair distribution of health in cost-effectiveness analysis. Click to show full abstract
This cross-sectional study evaluates a systematic drug appraisal method that uses severity of disease to account for a fair distribution of health in cost-effectiveness analysis.
               
Click one of the above tabs to view related content.